<DOC>
	<DOCNO>NCT01347086</DOCNO>
	<brief_summary>The aim study evaluate safety , tolerability pharmacokinetics Asian Caucasian healthy male volunteer administer BI 207127 NA .</brief_summary>
	<brief_title>Single Rising Dose Study BI 207127 NA Healthy Male Asian Volunteers Single Dose Study BI 207127 NA Healthy Male Caucasian Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male volunteer 2 . Chinese ethnicity Japanese ethnicity Caucasian 3 . Body Mass Index ( BMI ) = 18.5 BMI =25 kg/m2 Japanese Chinese , BMI =18.5 BMI = 29.9 kg/m2 Caucasians Exclusion criterion : 1 . Any finding medical examination ( include Blood pressure ( BP ) , Pulse rate ( PR ) Electrocardiogram ( ECG ) ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>